{"id":"W4408868147","doi":"10.1038/s41408-025-01243-7","title":"Correction: The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development","year":2025,"lang":"en","type":"erratum","venue":"Blood Cancer Journal","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Multiple myeloma; Medicine; Refractory (planetary science); Drug development; Internal medicine; Drug; Oncology; Intensive care medicine; Pharmacology; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009472636,0.002034639,0.001749826,0.003382111,0.002336436,0.005074032,0.003058562,0.005989751,0.03440427],"category_scores_gemma":[0.115354,0.001176754,0.00260954,0.002576946,0.002366458,0.002803827,0.001723161,0.01723001,0.02915152],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00395669,"about_ca_system_score_gemma":0.007729658,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01540218,"about_ca_topic_score_gemma":0.01716137,"domain_scores_codex":[0.9918702,0.001549309,0.001809936,0.0009521339,0.003284603,0.0005338766],"domain_scores_gemma":[0.9329129,0.0202944,0.003179386,0.003984077,0.03739954,0.002229667],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003400765,0.000004258213,0.00003363623,0.00008516848,0.000009039465,0.0001043169,0.0000145731,0.00003361017,0.00002752648,0.0005631841,0.9932387,0.005852004],"study_design_scores_gemma":[0.00005974723,0.00002390647,0.0003040956,0.0004604105,0.00004075301,0.0004533325,0.00003739692,0.0001712255,0.0002170798,0.001388228,0.9968141,0.00002970491],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"other","genre_scores_codex":[0.00008429017,0.001240691,0.0009121928,0.05183598,0.9425102,0.00002566403,0.001130753,0.0003603064,0.001899795],"genre_scores_gemma":[0.01005094,0.01363717,0.01129717,0.1742209,0.6615899,0.0002751446,0.003627087,0.002880057,0.1224217],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.03440427,"threshold_uncertainty_score":0.1150938,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07078477127089412,"score_gpt":0.3992426327131807,"score_spread":0.3284578614422866,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}